We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
-4.54%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$130M
AUM Growth
+$26.6M
(+26%)
Cap. Flow
+$34M
Cap. Flow
% of AUM
26.04%
Top 10 Holdings %
Top 10 Hldgs %
9.96%
Holding
800
New
284
Increased
141
Reduced
77
Closed
294
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sensata Technologies
ST
|
+$1.38M |
| 2 |
Mastercard
MA
|
+$1.33M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.33M |
| 4 |
Abbott
ABT
|
+$1.31M |
| 5 |
Universal Health Services
UHS
|
+$1.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.17M |
| 2 |
Teradata
TDC
|
+$1.08M |
| 3 |
Phillips 66
PSX
|
+$1.05M |
| 4 |
Marathon Petroleum
MPC
|
+$1.05M |
| 5 |
Pentair
PNR
|
+$1.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.22% |
| 2 | Financials | 13.03% |
| 3 | Industrials | 12.41% |
| 4 | Technology | 11.95% |
| 5 | Healthcare | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Dillards
DDS
$9.2B
| $43.6K | 0.03% |
400
+200
| +100% | +$23.2K |
|
|
AEGR
402
DELISTED
Aegerion Pharmaceuticals
AEGR
| $43.4K | 0.03% |
1,300
-3,100
| -70% | -$96.2K |
|
|
SVU
403
DELISTED
SUPERVALU Inc.
SVU
| $42.9K | 0.03% |
+686
| New | +$44.1K |
|
404
Royal Bank of Canada
RY
$287B
| $42.9K | 0.03% |
+600
| New | +$44.2K |
|
405
Designer Brands
DBI
$315M
| $42.2K | 0.03% |
1,400
-9,600
| -87% | -$275K |
|
406
Trip.com Group
TCOM
$29B
| $40.4K | 0.03% |
+1,424
| New | +$45.2K |
|
|
BYI
407
DELISTED
BALLY TECHNOLOGIES, INC.
BYI
| $40.4K | 0.03% |
+500
| New | +$36.4K |
|
|
INVN
408
DELISTED
Invensense Inc
INVN
| $39.9K | 0.03% |
+2,020
| New | +$47.6K |
|
409
SK Telecom
SKM
$11.4B
| $39.4K | 0.03% |
+789
| New | +$37.4K |
|
|
WOOF
410
DELISTED
VCA Inc.
WOOF
| $39.3K | 0.03% |
1,000
-1,900
| -66% | -$73.3K |
|
411
Sabesp
SBS
$18.4B
| $38.9K | 0.03% |
+24,751
| New | +$44.8K |
|
412
American Eagle Outfitters
AEO
$2.94B
| $38.8K | 0.03% |
+2,669
| New | +$32.8K |
|
|
PX
413
DELISTED
Praxair Inc
PX
| $38.7K | 0.03% |
+300
| New | +$39.3K |
|
|
414
Teradata
TDC
$2.88B
| $37.8K | 0.03% |
902
-25,200
| -97% | -$1.08M |
|
415
Viatris
VTRS
$20.8B
| $37.8K | 0.03% |
+831
| New | +$40.4K |
|
416
Warner Bros
WBD
$64.3B
| $37.8K | 0.03% |
1,000
-2,914
| -74% | -$121K |
|
|
HES
417
DELISTED
Hess
HES
| $37.7K | 0.03% |
+400
| New | +$39.6K |
|
418
Broadridge
BR
$18.4B
| $37.5K | 0.03% |
+900
| New | +$37.4K |
|
419
Allison Transmission
ALSN
$9.51B
| $37K | 0.03% |
1,300
+100
| +8% | +$3.04K |
|
420
Edgewell Personal Care
EPC
$1.3B
| $37K | 0.03% |
+405
| New | +$36.2K |
|
421
Autoliv
ALV
$9.14B
| $36.8K | 0.03% |
+555
| New | +$40.8K |
|
|
WCG
422
DELISTED
Wellcare Health Plans, Inc.
WCG
| $35.9K | 0.03% |
595
+200
| +51% | +$13.3K |
|
|
SAFM
423
DELISTED
Sanderson Farms Inc
SAFM
| $35.2K | 0.03% |
+400
| New | +$37.8K |
|
424
MSC Industrial Direct
MSM
$6.76B
| $34.2K | 0.03% |
400
-2,500
| -86% | -$223K |
|
425
Becton Dickinson
BDX
$46.4B
| $34.1K | 0.03% |
+308
| New | +$35.1K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q3 2014 Portfolio in Review
As of Q3 2014, Seven Eight Capital held 800 positions worth $130M, up 26% from $104M the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Seven Eight Capital deployed $34M of net new capital in Q3 2014, opening 284 new positions and adding to 141 existing holdings. Its largest new stake was Sensata Technologies: 29,200 shares worth $1.3M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 13% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Teradata, an estimated $1.08M trimmed.
- Seven Eight Capital's largest Q3 2014 buy was Sensata Technologies: 29,200 shares worth $1.3M.
- Seven Eight Capital added most to Medtronic in Q3 2014, an estimated $1.27M increase.
- Seven Eight Capital's biggest Q3 2014 reduction was Teradata, cutting an estimated $1.08M.
- Seven Eight Capital fully exited Allergan plc in Q3 2014, selling an estimated $1.17M.
- Seven Eight Capital's ten largest holdings make up 10% of its $130M portfolio in Q3 2014.
- Seven Eight Capital opened 284 new positions and closed 294 in Q3 2014.
- Seven Eight Capital's portfolio value rose 26% quarter-over-quarter to $130M.
Based on Seven Eight Capital's 13F filing for Q3 2014, filed 13 Nov 2014.